Professional Documents
Culture Documents
The Aspect of Gene Therapy
The Aspect of Gene Therapy
The Aspect of Gene Therapy
OF GENE
THERAPY
Group 2
Gene therapy has been around for about 50 years and is
currently the accepted standard of treatment for some
procedures, including bone marrow transplants.
This cutting-edge science has advanced significantly
over the last ten years and has shown promise in the
treatment of a wide range of common and uncommon
illnesses, including diabetes, Parkinson's disease, stroke,
autism, and spinal cord injuries.
In 2013, La Union Rep. Eufranio Eriguel has introduced
House Bill No. 212, which would put up a “bioethics
advisory board” that would establish “ethical
standards”governing the practice of stem cell therapy.
Its purpose is to make the country ahavenfor open
technological innovation for stem cell, and will promote
investment andgenerate jobs.
Substituting a healthy copy of a gene for a defective gene that causes illness.
Turning off a mutant gene that isn't working correctly, or "knocking it out.“
Introducing a novel gene into the body with the aim of combating an illness.
In most cases, a gene that is directly introduced into a cell is
not functional. Rather, the gene is delivered using a
genetically modified vector.
Because they can transfer the new gene by infecting the cell,
certain viruses are frequently utilized as vectors.
The viruses have been altered so that using them on humans
would not result in illness.
Various kinds of
Certain viruses—like retroviruses—integrate their genetic
material, including the newgene, into a human cell's
chromosome.
Adenoviruses and other viruses insert their DNA into the
cell's nucleus, but the DNA does not become incorporated
into a chromosome.
Gene therapy is a potentially useful treatment for many diseases,
but it is still a dangerous procedure that is being studied to
ensure its safety and efficacy. Only illnesses for which there are
no known treatments are being investigated for gene therapy.
Types Of Gene Therapy
types of cellsaretreated :
Somatic gene therapy Transferring a portion
involves transferring a
of DNA to cells that
specific DNA segment
make eggs or sperm is
to any bodily cell that
known as germline
is incapable of
gene therapy. Gene
producing sperm or
therapy will have an
eggs. The patient's
impact on the patient's
offspring won't be
offspring as well as
affected by the gene
future generations.
therapy.
STEM CELL
The body's unique stem cells are capable of
differentiating into many types of cells. They are
able to replenish lost cells because to this capacity.
owing to
With this skill, people with specific diseases or
flaws have had faulty cells replaced or controlled.
Adult stem cells can be obtained autologously
from three sources:
1. Bone marrow, harvested by
aspiration, is used to treat patient
undergoingchemotherapy.
Who determines what characteristics are normal and what qualifies as a disease or handicap?
Will only the wealthy have access to gene therapy due to its high cost?
Might society become less accepting of those who are different as a result of the widespread use of
gene therapy?
Is it acceptable for people to employ gene therapy to improve inherited characteristics like height, IQ,
or athleticism?
Despite the many successes of stem cells, the legislation pertaining to the use of gene therapy is rarely discussed in
scientific circles due to strong opposition to contentious debate, particularly regarding the actions of the professionals
involved—doctor, researcher, patient, and other individuals involved in medical and public health issues. the use of these
clinical trials.
These viewpoints are, nevertheless, obscured by questionable practices, and the outcomes of the current research
programs are uncertain. Everyone has the right to life, as stated in the Universal Declaration of Human Rights, but there
is a debate about how much of this right we are willing to jeopardize for the sake of still
incomplete scientific investigation.
As in other research domains, the validation of novel therapeutic approaches is intricately linked to the advancement of
clinical trials; hence, prior authorization from regional, national, and global ethical committees is mandatory. Adenoviral
and retroviral vectors, in particular, have caused major and sometimes fatal adverse effects.
Consequently, it appears that security is the primary barrier to the use of this kind of
clinical intervention in public health settings, such as hospitals. In close proximity to the novel technology advancements
utilized in contemporary healthcare, numerous ethical and moral issues were brought up with